Penny Stocks in the News - Vivendi SA-ADR(OTCMKTS:VIVHY), NanoViricides Inc(OTCBB:NNVCD), 3D EYE SOLUTIONS, IN(OTCMKTS:TDEY), KV Pharmaceutical Co(OTCMKTS:KVPHQ)

Lewes, DE -- (SBWire) -- 09/17/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Vivendi SA-ADR(OTCMKTS:VIVHY), NanoViricides Inc(OTCBB:NNVCD), 3D EYE SOLUTIONS, IN(OTCMKTS:TDEY), KV Pharmaceutical Co(OTCMKTS:KVPHQ).

Vivendi SA-ADR(OTCMKTS:VIVHY) ended higher +1.00% and complete the day at $23.24. The total number of shares changed hands during the day was 223,250. After opening at $23.30, the stock hit as high as $23.45. However, it traded between $18.33 and $23.45 over the last twelve months.

Vivendi Société Anonyme produces, publishes, and distributes digital products and services primarily in France and rest of Europe, the United States, Morocco, Brazil, and internationally

For How Long VIVHY will Fight for Profitability? Read This Trend Analysis report

NanoViricides Inc(OTCBB:NNVCD) closed yesterday at $3.65, a +1.39% increase. Around 261,349 shares were traded, beating an-average trading volume of 193,005 shares. The company is now valued at around $171.59 million.

NanoViricides, Inc., a nano-biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of viral infections

For How Long NNVCD Gloss will Attract Investors? Find out via this report

3D EYE SOLUTIONS, IN(OTCMKTS:TDEY) moved +7.14 percent higher at $0.0015 and traded between $0.0013 and $0.0019 after opening the day at $0.0016. Its performance over the last five days remained 87.5%, which stands at 7.14% for a month. Going back further than one month, 1-year performance after recent close was 150%.

3D Eye Solutions, Inc. engages in developing, providing, and integrating content conversion service for the 3D stereo and auto-stereo media industry in the United States

For How Long TDEY Gloss will Attract Investors? Find out via this report

KV Pharmaceutical Co(OTCMKTS:KVPHQ) shares fall, losing -66.80 percent to close at $0.0080. The stock is down around -97.5% this year and -97.5% for the last 12 months. Around 8.16 million shares changed hands yesterday, higher from an-average trading volume of 3.52 million shares.

K-V Pharmaceutical Company operates as a specialty branded pharmaceutical marketing company primarily focusing on women?s health care in the United States

Will KVPHQ Get Buyers Even After The Recent Rally? Find Out Here

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/

Media Relations Contact

News Department
http://leadingstockalerts.com/

View this press release online at: http://rwire.com/332628